TBCR Reading Tools
How to cite item
Pyrotinib plus capecitabine for human epidermal factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TBCR}{41552}, author = {Yan, M., Bian, L., Hu, X., Zhang, Q., Ouyang, Q., Feng, J., Yin, Y., Sun, T., Tong, Z., Wang, X., Yao, H., Zou, J., Zhu, X., Jiang, Z.}, title = {Pyrotinib plus capecitabine for human epidermal factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study}, journal = {Translational Breast Cancer Research}, volume = {1}, number = {0}, year = {2020}, url = {https://tbcr.amegroups.org/article/view/41552} }